当前位置:
X-MOL 学术
›
Nat. Rev. Drug. Disc.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
FDA rejects first-in-class osteoporosis drug
Nature Reviews Drug Discovery ( IF 120.1 ) Pub Date : , DOI: 10.1038/nrd.2017.176 Asher Mullard
Nature Reviews Drug Discovery ( IF 120.1 ) Pub Date : , DOI: 10.1038/nrd.2017.176 Asher Mullard
FDA rejects first-in-class osteoporosis drug
中文翻译:
FDA拒绝一流的骨质疏松症药物
FDA拒绝一流的骨质疏松症药物
更新日期:2017-09-07
Nature Reviews Drug Discovery, Published online: 1 September 2017; doi:10.1038/nrd.2017.176
中文翻译:
FDA拒绝一流的骨质疏松症药物
FDA拒绝一流的骨质疏松症药物
Nature Reviews Drug Discovery,在线发布:2017年9月1日;doi:10.1038 / nrd.2017.176